HIGH

Advanced Pharmaceutical Technology Recalls Testosterone Pellets Due to Contamination Risk

Advanced Pharmaceutical Technology recalled 22,843 cartons of TESTO-100 CIII testosterone pellets on October 3, 2025. The recall follows a risk of microbial contamination that could compromise product sterility. Consumers and healthcare providers should stop using the product immediately and seek guidance.

Quick Facts at a Glance

Recall Date
October 3, 2025
Hazard Level
HIGH
Brand
Advanced Pharmaceutical Technology
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
3 states
At-Risk Groups
GENERAL

Hazard Information

Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Advanced Pharmaceutical Technology, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

TESTO-100 CIII testosterone pellets are used for testosterone replacement therapy in men with low testosterone levels. These pellets offer a convenient method of hormone delivery, usually implanted under the skin.

Why This Is Dangerous

The potential microbial contamination in these pellets poses a risk of infections or other health complications if used. This contamination can occur during the manufacturing process, compromising the product's safety.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks if they use the contaminated product. Stopping use and seeking alternative treatments is critical for safety.

Practical Guidance

How to identify if yours is affected

  1. Check the product packaging for the lot number P-22-3.
  2. Verify the expiration date, which should be June 2027.
  3. If you have the product, confirm it matches the recalled lot and expiration.

Where to find product info

The lot number and expiration date can be found on the packaging of the product.

What timeline to expect

Expect a timeline of 4-6 weeks for refund processing after returning the product.

If the manufacturer is unresponsive

  • Document your attempts to contact the manufacturer.
  • Reach out to your healthcare provider for additional support.
  • Consider filing a complaint with the FDA if you receive no response.

How to prevent similar issues

  • Always check for recalls before using medications or supplements.
  • Look for FDA approval and certification when purchasing health products.
  • Consult with healthcare providers about any concerns regarding medications.

Documentation advice

Keep records of your correspondence with the manufacturer, including any confirmation letters or emails.

Product Details

The recall involves TESTO-100 CIII testosterone pellets, 100 mg, sold in cartons of 10 sterile pellets. The affected lot number is P-22-3, with an expiration date of June 2027. The product was distributed in Georgia, New York, Texas, Puerto Rico, the United Kingdom, Malta, and Greece.

Key Facts

  • Recall date: October 3, 2025
  • Quantity recalled: 22,843 pellets
  • Affected lot number: P-22-3
  • Expiration date: June 2027
  • Distribution states: GA, NY, TX, Puerto Rico, UK, Malta, Greece

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot #: P-22-3
Exp 06-2027
Affected States
GA, NY, TX
Report Date
January 21, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more